Literature DB >> 31212012

Drug-induced endocrine blood pressure elevation.

Katharina R Beck1, George R Thompson2, Alex Odermatt3.   

Abstract

Patients with uncontrolled hypertension are at risk for cardiovascular complications. The majority of them suffers from unidentified forms of hypertension and a fraction has so-called secondary hypertension with an identifiable cause. The patient's medications, its use of certain herbal supplements and over-the-counter agents represent potential causal factors for secondary hypertension that are often overlooked. The current review focuses on drugs that are likely to elevate blood pressure by affecting the human endocrine system at the level of steroid synthesis or metabolism, mineralocorticoid receptor activity, or by affecting the catecholaminergic system. Drugs with known adverse effects but where benefits outweigh their risks, drug candidates and market withdrawals are reviewed. Finally, potential therapeutic strategies are discussed.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  11beta-hydroxysteroid dehydrogenase; Abiraterone; Adverse drug reaction; Carbenoxolone; Catecholamine; Danazol; Etomidate; Hypertension; Itraconazole; Ketoconazole; Lisdexamphetamine; Metyrapone; Mifepristone; Mineralocorticoid excess; Posaconazole; Steroidogenesis

Mesh:

Substances:

Year:  2019        PMID: 31212012     DOI: 10.1016/j.phrs.2019.104311

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  3 in total

1.  Data science-driven analyses of drugs inducing hypertension as an adverse effect.

Authors:  Reetu Sharma
Journal:  Mol Divers       Date:  2020-05-15       Impact factor: 2.943

2.  High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice.

Authors:  Gonzalo Jorquera; Roberto Meneses-Valdés; Giovanni Rosales-Soto; Denisse Valladares-Ide; Cristian Campos; Mónica Silva-Monasterio; Paola Llanos; Gonzalo Cruz; Enrique Jaimovich; Mariana Casas
Journal:  Diabetologia       Date:  2021-03-12       Impact factor: 10.122

3.  A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling.

Authors:  Laura Maria Fuhr; Fatima Zahra Marok; Maximilian Mees; Felix Mahfoud; Dominik Selzer; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.